Affordable Access

Publisher Website

In vitro activity of garenoxacin against recent clinical isolates ofChlamydia pneumoniae

Authors
Journal
International Journal of Antimicrobial Agents
0924-8579
Publisher
Elsevier
Publication Date
Volume
21
Issue
6
Identifiers
DOI: 10.1016/s0924-8579(03)00061-x
Keywords
  • Chlamydiapneumoniae
  • Garenoxacin
  • Mic
  • Fluoroquinolones

Abstract

Abstract The in vitro activities of garenoxacin, a novel des-F (6)-quinolone, levofloxacin, moxifloxacin and clarithromycin were tested against 30 recent clinical isolates of Chlamydia pneumoniae. The minimal inhibitory concentration (MIC) at which 90% of the isolates were inhibited and the minimal bactericidal concentration (MBC) at which 90% of the isolates were killed by garenoxacin for C. pneumoniae was 0.03 mg/l (range 0.015–0.03 mg/l).

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

In vitro activity of garenoxacin against recent cl...

on International Journal of Antim... June 2003

Activity of grepafloxacin and other fluoroquinones...

on International Journal of Antim... Jan 01, 1999

The in vitro activity of a new fluoroquinolone, AB...

on The Journal of antimicrobial c... July 2004

In vitro antibiotic activity against Chlamydia pne...

on Journal of chemotherapy (Flore... February 2003
More articles like this..